Skip to main content
. 2020 Aug 26;20(5):18. doi: 10.3892/etm.2020.9145

Figure 1.

Figure 1

Effect of rAd-p53 and/or curcumin treatment on the viability of hepatocytes and liver cancer cells. Cell Counting Kit-8 analysis of the effect of rAd-p53 and/or curcumin on (A) HHL-5, (B) Hep3B, (C) Huh-7 and (D) HepG2 cells. (E) HepG2 cell viability after the discontinuation of rAD-p53 and/or curcumin. Data are represented as mean ± standard deviation (n =3). &&P<0.01 vs. Con, **P<0.01 vs. Con, #P<0.05 vs. Cur and ##P<0.01 vs. Cur. Cur, curcumin; rAd-p53, recombinant human adenovirus-p53; Con, control.